Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001
Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001 |
https://doi.org/10.18632/oncotarget.28341
Xiaofan Li,
Cristina Abrahams,
Abigail Yu,
Millicent Embry,
Robert Henningsen,
Venita DeAlmeida,
Shannon Matheny,
Toni Kline,
Alice Yam,
Ryan Stafford,
Trevor Hallam,
Mark Lupher,
and Arturo Molina
|
1-13 |
Candidate drugs associated with sensitivity of cancer cell lines with DLST amplification or high mRNA levels
Candidate drugs associated with sensitivity of cancer cell lines with DLST amplification or high mRNA levels |
https://doi.org/10.18632/oncotarget.28342
Christina Kuhn,
Myriam Boeschen,
Manuel Philip,
Torsten Schöneberg,
Doreen Thor,
and Susanne Horn
|
14-20 |
Correction: MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastoma
Correction: MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastoma |
https://doi.org/10.18632/oncotarget.28336
David King,
Xiao Dun Li,
Gilberto S. Almeida,
Colin Kwok,
Polly Gravells,
Daniel Harrison,
Saoirse Burke,
Albert Hallsworth,
Yann Jamin,
Sally George,
Simon P. Robinson,
Christopher J. Lord,
Evon Poon,
Daniel Yeomanson,
Louis Chesler,
and Helen E. Bryant
|
21-22 |
The chromatographic constitution of andiroba oil and its healing effects, compared to the LLLT outcomes, in oral mucositis induced in golden Syrian hamsters: a new treatment option
The chromatographic constitution of andiroba oil and its healing effects, compared to the LLLT outcomes, in oral mucositis induced in golden Syrian hamsters: a new treatment option |
https://doi.org/10.18632/oncotarget.28338
Jessica T. Gomes,
Ana Márcia V. Wanzeler,
Sergio M.A. Júnior,
Rosa Helena F. Chaves Soares,
Carolina P. de Oliveira,
Emanuelle de M. Rodrigues,
Bruno M. Soares,
Diego D.F.A. Alcantara,
Rommel M.R. Burbano,
and Fabrício M. Tuji
|
23-39 |
Intraventricular immunovirotherapy; a translational step forward
Intraventricular immunovirotherapy; a translational step forward |
https://doi.org/10.18632/oncotarget.28343
Joshua D. Bernstock,
Sarah Blitz,
Kyung-Don Kang,
and Gregory K. Friedman
|
40-43 |
Correction: IGF-1 and hyperglycaemia-induced FOXA1 and IGFBP-2 affect epithelial to mesenchymal transition in prostate epithelial cells
Correction: IGF-1 and hyperglycaemia-induced FOXA1 and IGFBP-2 affect epithelial to mesenchymal transition in prostate epithelial cells |
https://doi.org/10.18632/oncotarget.28344
Rehanna Mansor,
Jeff Holly,
Rachel Barker,
Kalina Biernacka,
Hanna Zielinska,
Anthony Koupparis,
Edward Rowe,
Jon Oxley,
Alex Sewell,
Richard M. Martin,
Athene Lane,
Lucy Hackshaw-McGeagh,
and Claire Perks
|
44-46 |
To be or not to be: the role of CD56 in multiple myeloma
To be or not to be: the role of CD56 in multiple myeloma |
https://doi.org/10.18632/oncotarget.28350
Francesca Cottini,
and Don Benson
|
47-49 |
Retraction: Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met
Retraction: Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met |
https://doi.org/10.18632/oncotarget.28329
Chengcao Sun,
Ming Sang,
Shujun Li,
Xiaodong Sun,
Cuili Yang,
Yongyong Xi,
Liang Wang,
Feng Zhang,
Yongyi Bi,
Yunfeng Fu,
and Dejia Li
|
50-50 |
Permeability and driving force: why is it difficult to control glycolytic flux by blocking lactate transporters?
Permeability and driving force: why is it difficult to control glycolytic flux by blocking lactate transporters? |
https://doi.org/10.18632/oncotarget.28351
Wiktoria Blaszczak,
and Pawel Swietach
|
51-52 |
Correction: Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells
Correction: Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells |
https://doi.org/10.18632/oncotarget.28345
Fiorella Vanderhoeven,
Analía Lourdes Redondo,
Ana Laura Martinez,
Laura María Vargas-Roig,
Angel Matias Sanchez,
and Marina Inés Flamini
|
53-53 |
The role of Kras and canonical Wnt pathways for tumorigenesis of extrahepatic biliary system
The role of Kras and canonical Wnt pathways for tumorigenesis of extrahepatic biliary system |
https://doi.org/10.18632/oncotarget.28349
Munemasa Nagao,
Akihisa Fukuda,
and Hiroshi Seno
|
54-56 |
Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659)
Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659) |
https://doi.org/10.18632/oncotarget.28352
Leo I. Gordon,
Reem Karmali,
Jason B. Kaplan,
Rakesh Popat,
Howard A. Burris III,
Silvia Ferrari,
Sumit Madan,
Manish R. Patel,
Giuseppe Gritti,
Dima El-Sharkawi,
F. Ian Chau,
John Radford,
Jaime Pérez de Oteyza,
Pier Luigi Zinzani,
Swaminathan P. Iyer,
William Townsend,
Harry Miao,
Igor Proscurshim,
Shining Wang,
Shilpi Katyayan,
Ying Yuan,
Jiaxi Zhu,
Kate Stumpo,
Yaping Shou,
Cecilia Carpio,
and Francesc Bosch
|
57-70 |
Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer
Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer |
https://doi.org/10.18632/oncotarget.28353
Noriyuki Hirahara,
Takeshi Matsubara,
Shunsuke Kaji,
Hikota Hayashi,
Yohei Sasaki,
Koki Kawakami,
Ryoji Hyakudomi,
Tetsu Yamamoto,
and Yoshitsugu Tajima
|
71-82 |
Correction: Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6
Correction: Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6 |
https://doi.org/10.18632/oncotarget.28115
Nicole Golob-Schwarzl,
Caroline Schweiger,
Carina Koller,
Stefanie Krassnig,
Margit Gogg-Kamerer,
Nadine Gantenbein,
Anna M. Toeglhofer,
Christina Wodlej,
Helmut Bergler,
Brigitte Pertschy,
Stefan Uranitsch,
Magdalena Holter,
Amin El-Heliebi,
Julia Fuchs,
Andreas Punschart,
Philipp Stiegler,
Marlen Keil,
Jens Hoffmann,
David Henderson,
Hans Lehrach,
Christoph Reinhard,
Christian Regenbrecht,
Rudolf Schicho,
Peter Fickert,
Sigurd Lax,
and Johannes Haybaeck
|
83-84 |
Everolimus downregulates STAT3/HIF-1α/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in TP53 mutant head and neck squamous cell carcinoma (HNSCC)
Everolimus downregulates STAT3/HIF-1α/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in TP53 mutant head and neck squamous cell carcinoma (HNSCC) |
https://doi.org/10.18632/oncotarget.28355
Md Maksudul Alam,
Janmaris Marin Fermin,
Mark Knackstedt,
Mackenzie J. Noonan,
Taylor Powell,
Landon Goodreau,
Emily K. Daniel,
Xiaohua Rong,
Tara Moore-Medlin,
Alok R. Khandelwal,
and Cherie-Ann O. Nathan
|
85-95 |
The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy
The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy |
https://doi.org/10.18632/oncotarget.28354
Anqi Shao,
and David M. Owens
|
96-103 |
Correction: KHSRP-bound small nucleolar RNAs associate with promotion of cell invasiveness and metastasis of pancreatic cancer
Correction: KHSRP-bound small nucleolar RNAs associate with promotion of cell invasiveness and metastasis of pancreatic cancer |
https://doi.org/10.18632/oncotarget.28361
Keisuke Taniuchi,
and Mitsunari Ogasawara
|
104-104 |
WNT-pathway medulloblastoma: what constitutes low-risk and how low can one go?
WNT-pathway medulloblastoma: what constitutes low-risk and how low can one go? |
https://doi.org/10.18632/oncotarget.28360
Shakthivel Mani,
Abhishek Chatterjee,
Archya Dasgupta,
Neelam Shirsat,
Sridhar Epari,
Girish Chinnaswamy,
and Tejpal Gupta
|
105-110 |
The “extreme phenotype approach” applied to male breast cancer allows the identification of rare variants of ATR as potential breast cancer susceptibility alleles
The “extreme phenotype approach” applied to male breast cancer allows the identification of rare variants of ATR as potential breast cancer susceptibility alleles |
https://doi.org/10.18632/oncotarget.28358
Martin Chevarin,
Diana Alcantara,
Juliette Albuisson,
Marie-Agnès Collonge-Rame,
Céline Populaire,
Zohair Selmani,
Amandine Baurand,
Caroline Sawka,
Geoffrey Bertolone,
Patrick Callier,
Yannis Duffourd,
Philippe Jonveaux,
Yves-Jean Bignon,
Isabelle Coupier,
François Cornelis,
Christophe Cordier,
Monique Mozelle-Nivoix,
Jean-Baptiste Rivière,
Paul Kuentz,
Christel Thauvin,
Romain Boidot,
François Ghiringhelli,
Marc O'Driscoll,
Laurence Faivre,
and Sophie Nambot
|
111-125 |
Addendum: Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation
Addendum: Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation |
https://doi.org/10.18632/oncotarget.28365
Karam Khaddour,
Joshua Dowling,
Jiayi Huang,
Martha Council,
David Chen,
Lynn Cornelius,
Tanner Johanns,
Sonika Dahiya,
and George Ansstas
|
126-126 |
Unveiling the non-canonical functions of EZH2 in prostate cancer
Unveiling the non-canonical functions of EZH2 in prostate cancer |
https://doi.org/10.18632/oncotarget.28357
Yang Yi,
Yanqiang Li,
Kaifu Chen,
and Qi Cao
|
127-128 |
Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma
Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma |
https://doi.org/10.18632/oncotarget.28346
Barbara Marengo,
Elda Meta,
Chiara Brullo,
Chiara De Ciucis,
Renata Colla,
Andrea Speciale,
Ombretta Garbarino,
Olga Bruno,
and Cinzia Domenicotti
|
129-130 |
Addendum: Prognostic significance of isochromosome 17q in hematologic malignancies
Addendum: Prognostic significance of isochromosome 17q in hematologic malignancies |
https://doi.org/10.18632/oncotarget.28295
Dorota Koczkodaj,
Justyna Muzyka-Kasietczuk,
Sylwia Chocholska,
and Monika Podhorecka
|
131-131 |
Unlocking the potential of molecular-driven stratification for osteosarcoma treatment and prognosis
Unlocking the potential of molecular-driven stratification for osteosarcoma treatment and prognosis |
https://doi.org/10.18632/oncotarget.28364
Gaël Moquin-Beaudry,
Maria Eugenia Marques da Costa,
Nathalie Gaspar,
and Antonin Marchais
|
132-132 |
Oncogenic driver FGFR3-TACC3 requires five coiled-coil heptads for activation and disulfide bond formation for stability
Oncogenic driver FGFR3-TACC3 requires five coiled-coil heptads for activation and disulfide bond formation for stability |
https://doi.org/10.18632/oncotarget.28359
Clark G. Wang,
Malalage N. Peiris,
April N. Meyer,
Katelyn N. Nelson,
and Daniel J. Donoghue
|
133-145 |
Leakage? or Secretion? unconventional protein secretion in cancer
Leakage? or Secretion? unconventional protein secretion in cancer |
https://doi.org/10.18632/oncotarget.28368
Kohji Yamada,
and Kiyotsugu Yoshida
|
146-147 |
Correction: Suppression of PKC causes oncogenic stress for triggering apoptosis in cancer cells
Correction: Suppression of PKC causes oncogenic stress for triggering apoptosis in cancer cells |
https://doi.org/10.18632/oncotarget.28251
Suthakar Ganapathy,
Bo Peng,
Ling Shen,
Tianqi Yu,
Jean Lafontant,
Ping Li,
Rui Xiong,
Alexandros Makriyannis,
and Changyan Chen
|
148-148 |
Addendum: Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment
Addendum: Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment |
https://doi.org/10.18632/oncotarget.28363
Gennady M. Zharinov,
Oleg A. Bogomolov,
Irina V. Chepurnaya,
Natalia Yu. Neklasova,
and Vladimir N. Anisimov
|
149-149 |
Mitochondria engage the integrated stress response to promote tumor growth
Mitochondria engage the integrated stress response to promote tumor growth |
https://doi.org/10.18632/oncotarget.28372
Dillon P. Boulton,
and M. Cecilia Caino
|
150-152 |
What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types
What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types |
https://doi.org/10.18632/oncotarget.28367
Christian Mark Farag,
Ryan Antar,
Sinan Akosman,
Matthew Ng,
and Michael J. Whalen
|
153-172 |
Retraction: Methylation-induced downregulation and tumor suppressive role of microRNA-29b in gastric cancer through targeting LASP1
Retraction: Methylation-induced downregulation and tumor suppressive role of microRNA-29b in gastric cancer through targeting LASP1 |
https://doi.org/10.18632/oncotarget.28381
Hui Li,
Guoqing Liu,
Ke Pan,
Xiongying Miao,
and Yong Xie
|
173-173 |
C/EBPβ cooperates with MYB to maintain the oncogenic program of AML cells
C/EBPβ cooperates with MYB to maintain the oncogenic program of AML cells |
https://doi.org/10.18632/oncotarget.28377
Karl-Heinz Klempnauer
|
174-177 |
Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss
Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss |
https://doi.org/10.18632/oncotarget.28376
Maroun Bou Zerdan,
Prashanth Ashok Kumar,
Elio Haroun,
Nimisha Srivastava,
Jeffrey Ross,
and Abirami Sivapiragasam
|
178-187 |
Correction: UBE2T knockdown inhibits gastric cancer progression
Correction: UBE2T knockdown inhibits gastric cancer progression |
https://doi.org/10.18632/oncotarget.28356
Changjiang Luo,
Yunyi Yao,
Zeyuan Yu,
Huinian Zhou,
Lingyun Guo,
Junqiang Zhang,
Hongtai Cao,
Genyuan Zhang,
Yumin Li,
and Zuoyi Jiao
|
188-189 |
Proof-of-principle: targeted childhood leukemia prevention
Proof-of-principle: targeted childhood leukemia prevention |
https://doi.org/10.18632/oncotarget.28371
César Cobaleda,
Manuel Ramírez-Orellana,
Carolina Vicente-Dueñas,
Andreas Weiss,
Kim E. Nichols,
and Isidro Sánchez-García
|
190-192 |
Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells
Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells |
https://doi.org/10.18632/oncotarget.28382
Mikhail V. Blagosklonny
|
193-206 |
Impact of cortactin in cancer progression on Wnt5a/ROR1 signaling pathway
Impact of cortactin in cancer progression on Wnt5a/ROR1 signaling pathway |
https://doi.org/10.18632/oncotarget.28386
Kamrul Hasan,
and Thomas J. Kipps
|
207-209 |
Correction: Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma
Correction: Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma |
https://doi.org/10.18632/oncotarget.28347
Yonghao Zhan,
Yifan Li,
Bao Guan,
Xiaoying Chen,
Zhicong Chen,
Anbang He,
Shiming He,
Yanqing Gong,
Ding Peng,
Yuchen Liu,
Zhiming Cai,
Xuesong Li,
and Liqun Zhou
|
210-210 |
Cancer-associated fibroblasts: challenges and opportunities
Cancer-associated fibroblasts: challenges and opportunities |
https://doi.org/10.18632/oncotarget.28385
Hossein Tavana,
and Gary D. Luker
|
211-214 |
Correction: Annexin A13 promotes tumor cell invasion in vitro and is associated with metastasis in human colorectal cancer
Correction: Annexin A13 promotes tumor cell invasion in vitro and is associated with metastasis in human colorectal cancer |
https://doi.org/10.18632/oncotarget.28247
Guozhong Jiang,
Pengju Wang,
Weiwei Wang,
Wencai Li,
Liping Dai,
and Kuisheng Chen
|
215-215 |
Therapy drives genomic evolution in metastatic cancer
Therapy drives genomic evolution in metastatic cancer |
https://doi.org/10.18632/oncotarget.28379
Ditte S. Christensen,
and Nicolai J. Birkbak
|
216-218 |
Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior
Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior |
https://doi.org/10.18632/oncotarget.28388
Fang Cheng,
Victor Chérouvrier Hansson,
Grigorios Georgolopoulos,
and Katrin Mani
|
219-235 |
Genetic modifiers of p53: opportunities for breast cancer therapies
Genetic modifiers of p53: opportunities for breast cancer therapies |
https://doi.org/10.18632/oncotarget.28387
Prabin Dhangada Majhi,
Aman Sharma,
and D. Joseph Jerry
|
236-241 |
Retraction: Overexpression of NR4A1 is associated with tumor recurrence and poor survival in non-small-cell lung carcinoma
Retraction: Overexpression of NR4A1 is associated with tumor recurrence and poor survival in non-small-cell lung carcinoma |
https://doi.org/10.18632/oncotarget.28396
Bing Zhu,
Jian-Ru Yang,
Yang Jia,
Pei Zhang,
Lin Shen,
Xiao-Long Li,
Jing Li,
and Bing Wang
|
242-242 |
Polyisoprenylated cysteinyl amide inhibitors deplete singly polyisoprenylated monomeric G-proteins in lung and breast cancer cell lines
Polyisoprenylated cysteinyl amide inhibitors deplete singly polyisoprenylated monomeric G-proteins in lung and breast cancer cell lines |
https://doi.org/10.18632/oncotarget.28390
Nada Tawfeeq,
Jassy Mary S. Lazarte,
Yonghao Jin,
Matthew D. Gregory,
and Nazarius S. Lamango
|
243-257 |
Neutrophil PAD4: how does it function in cancer beyond promoting NETosis?
Neutrophil PAD4: how does it function in cancer beyond promoting NETosis? |
https://doi.org/10.18632/oncotarget.28369
Laura Garcia-Gerique,
and Yulia Nefedova
|
258-260 |
Downregulation of angulin-1/LSR induces malignancy via upregulation of EGF-dependent claudin-2 and TGF-β-dependent cell metabolism in human lung adenocarcinoma A549 cells
Downregulation of angulin-1/LSR induces malignancy via upregulation of EGF-dependent claudin-2 and TGF-β-dependent cell metabolism in human lung adenocarcinoma A549 cells |
https://doi.org/10.18632/oncotarget.27728
Wataru Arai,
Takumi Konno,
Takayuki Kohno,
Yuki Kodera,
Mitsuhiro Tsujiwaki,
Yuma Shindo,
Hirofumi Chiba,
Masahiro Miyajima,
Yuji Sakuma,
Atsushi Watanabe,
and Takashi Kojima
|
261-275 |
p53 protects against formation of extrahepatic biliary precancerous lesions in the context of oncogenic Kras
p53 protects against formation of extrahepatic biliary precancerous lesions in the context of oncogenic Kras |
https://doi.org/10.18632/oncotarget.28380
Munemasa Nagao,
Kenta Mizukoshi,
Shinnosuke Nakayama,
Mio Namikawa,
Yukiko Hiramatsu,
Takahisa Maruno,
Yuki Nakanishi,
Tatsuaki Tsuruyama,
Akihisa Fukuda,
and Hiroshi Seno
|
276-279 |
Correction: YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinoma
Correction: YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinoma |
https://doi.org/10.18632/oncotarget.28393
Tao Guo,
Shilei Zhao,
Peng Wang,
Xiaoyuan Xue,
Yan Zhang,
Mengying Yang,
Nan Li,
Zhuoshi Li,
Lingzhi Xu,
Lei Jiang,
Lei Zhao,
Patrick C. Ma,
Rafael Rosell,
Jinxiu Li,
and Chundong Gu
|
280-280 |
Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors
Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors |
https://doi.org/10.18632/oncotarget.28392
Giulia Franciosa,
and Jesper V. Olsen
|
281-283 |
Crosstalk between triple negative breast cancer and microenvironment
Crosstalk between triple negative breast cancer and microenvironment |
https://doi.org/10.18632/oncotarget.28397
Karly Smrekar,
Artem Belyakov,
and Kideok Jin
|
284-293 |
Retraction: Significance of B10 cell in patients with thymoma complicated with myasthenia gravis
Retraction: Significance of B10 cell in patients with thymoma complicated with myasthenia gravis |
https://doi.org/10.18632/oncotarget.28160
Yang Lu,
Fanjie Meng,
Yang Yang,
Lan Li,
Donghao Wang,
Yuantao Cui,
Shangwen Dong,
and Wanhua Wang
|
294-294 |
Tumor necroptosis promotes metastasis through modulating the interplay between tumor and host immunity
Tumor necroptosis promotes metastasis through modulating the interplay between tumor and host immunity |
https://doi.org/10.18632/oncotarget.28404
Zhaoshan Liu,
Swati Choksi,
and Zheng-Gang Liu
|
295-296 |
EGFR endocytosis: more than meets the eye
EGFR endocytosis: more than meets the eye |
https://doi.org/10.18632/oncotarget.28400
Aysegul Sapmaz,
and Ayse Elif Erson-Bensan
|
297-301 |
A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850
A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850 |
https://doi.org/10.18632/oncotarget.28403
Kristen R. Spencer,
Daniella E. Portal,
Joseph Aisner,
Mark N. Stein,
Jyoti Malhotra,
Weichung Shih,
Nancy Chan,
Ann W. Silk,
Shridar Ganesan,
Susan Goodin,
Murugesan Gounder,
Hongxia Lin,
Jiadong Li,
Robert Cerchio,
Christina Marinaro,
Suzie Chen,
and Janice M. Mehnert
|
302-315 |
Correction: Calcitonin receptor is required for T-antigen-induced prostate carcinogenesis
Correction: Calcitonin receptor is required for T-antigen-induced prostate carcinogenesis |
https://doi.org/10.18632/oncotarget.28394
Ajay Kale,
Afaf Aldahish,
and Girish Shah
|
316-316 |
The nuclear envelope and metastasis
The nuclear envelope and metastasis |
https://doi.org/10.18632/oncotarget.28375
Emily Hansen,
and James M. Holaska
|
317-320 |
Adopted neoplastic cells and the consequences of their existence
Adopted neoplastic cells and the consequences of their existence |
https://doi.org/10.18632/oncotarget.28408
Yuri Lazebnik
|
321-341 |
Cancer prevention with rapamycin
Cancer prevention with rapamycin |
https://doi.org/10.18632/oncotarget.28410
Mikhail V. Blagosklonny
|
342-350 |
Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study
Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study |
https://doi.org/10.18632/oncotarget.28406
Ellery Altshuler,
Raymond Richhart,
William King,
Mahmoud Aryan,
Akash Mathavan,
Akshay Mathavan,
Keegan Hones,
Daniel F. Leach III,
Logan Pucci,
Joshua Riklan,
Pat Haley,
Ilyas Sahin,
Brian Ramnaraign,
Sherise Rogers,
Ibrahim Nassour,
Steven Hughes,
Thomas J. George,
and Jesus Fabregas
|
351-357 |
Crossroads: the role of biomarkers in the management of lumps in the breast
Crossroads: the role of biomarkers in the management of lumps in the breast |
https://doi.org/10.18632/oncotarget.28402
Georg F. Weber
|
358-362 |
Retraction: LncRNA NEAT1 enhances the radio-resistance of cervical cancer via miR-193b-3p/CCND1 axis
Retraction: LncRNA NEAT1 enhances the radio-resistance of cervical cancer via miR-193b-3p/CCND1 axis |
https://doi.org/10.18632/oncotarget.28416
Dongmei Han,
Jianfeng Wang,
and Guanghui Cheng
|
363-363 |
The critical immune basis for differential responses to immunotherapy in primary versus metastatic pancreatic cancer
The critical immune basis for differential responses to immunotherapy in primary versus metastatic pancreatic cancer |
https://doi.org/10.18632/oncotarget.28373
Brian Diskin,
Sarah Schwartz,
and George Miller
|
364-365 |
Differential silencing of STAT3 isoforms leads to changes in STAT3 activation
Differential silencing of STAT3 isoforms leads to changes in STAT3 activation |
https://doi.org/10.18632/oncotarget.28412
Inbal Shamir,
Ilan Tsarfaty,
Gidi Paret,
and Yael Nevo-Caspi
|
366-376 |
Disruption of retinol-mediated IL-6 expression in colon cancer-associated fibroblasts: new perspectives on the role of vitamin A metabolism
Disruption of retinol-mediated IL-6 expression in colon cancer-associated fibroblasts: new perspectives on the role of vitamin A metabolism |
https://doi.org/10.18632/oncotarget.28399
Romain Villéger,
Marina Chulkina,
Randy C. Mifflin,
Don W. Powell,
and Irina V. Pinchuk
|
377-381 |
A balancing act: how whole-genome doubling and aneuploidy interact in human cancer
A balancing act: how whole-genome doubling and aneuploidy interact in human cancer |
https://doi.org/10.18632/oncotarget.28374
Kavya Prasad,
and Uri Ben-David
|
382-383 |
Systemic AL amyloidosis: current approach and future direction
Systemic AL amyloidosis: current approach and future direction |
https://doi.org/10.18632/oncotarget.28415
Maroun Bou Zerdan,
Lewis Nasr,
Farhan Khalid,
Sabine Allam,
Youssef Bouferraa,
Saba Batool,
Muhammad Tayyeb,
Shubham Adroja,
Mahinbanu Mammadii,
Faiz Anwer,
Shahzad Raza,
and Chakra P. Chaulagain
|
384-394 |
AGO2 in T-prolymphocytic leukemia: its canonical and non-canonical deregulation and function
AGO2 in T-prolymphocytic leukemia: its canonical and non-canonical deregulation and function |
https://doi.org/10.18632/oncotarget.28378
Till Braun,
Hanna Klepzig,
and Marco Herling
|
395-397 |
Retraction: Overexpression of microRNA-132 enhances the radiosensitivity of cervical cancer cells by down-regulating Bmi-1
Retraction: Overexpression of microRNA-132 enhances the radiosensitivity of cervical cancer cells by down-regulating Bmi-1 |
https://doi.org/10.18632/oncotarget.28413
Gui-Feng Liu,
Shu-Hua Zhang,
Xue-Feng Li,
Li-Yan Cao,
Zhan-Zhao Fu,
and Shao-Nan Yu
|
398-398 |
Using cancer proteomics data to identify gene candidates for therapeutic targeting
Using cancer proteomics data to identify gene candidates for therapeutic targeting |
https://doi.org/10.18632/oncotarget.28420
Diana Monsivais,
Sydney E. Parks,
Darshan S. Chandrashekar,
Sooryanarayana Varambally,
and Chad J. Creighton
|
399-412 |
From the groin to the brain: a transfemoral path to blood-brain barrier opening
From the groin to the brain: a transfemoral path to blood-brain barrier opening |
https://doi.org/10.18632/oncotarget.28414
Thomas C. Chen,
Weijun Wang,
and Axel H. Schönthal
|
413-416 |
Correction: Connexin 43 expression is associated with increased malignancy in prostate cancer cell lines and functions to promote migration
Correction: Connexin 43 expression is associated with increased malignancy in prostate cancer cell lines and functions to promote migration |
https://doi.org/10.18632/oncotarget.28411
Ao Zhang,
Masahiro Hitomi,
Noah Bar-Shain,
Zafardjan Dalimov,
Leigh Ellis,
Kiran K. Velpula,
Gail C. Fraizer,
Robert G. Gourdie,
and Justin D. Lathia
|
417-418 |
Targeting cellular respiration as a therapeutic strategy in glioblastoma
Targeting cellular respiration as a therapeutic strategy in glioblastoma |
https://doi.org/10.18632/oncotarget.28424
Enyuan Shang,
Trang Thi Thu Nguyen,
Mike-Andrew Westhoff,
Georg Karpel-Massler,
and Markus D. Siegelin
|
419-425 |
Human LY6 gene family: potential tumor-associated antigens and biomarkers of prognosis in uterine corpus endometrial carcinoma
Human LY6 gene family: potential tumor-associated antigens and biomarkers of prognosis in uterine corpus endometrial carcinoma |
https://doi.org/10.18632/oncotarget.28409
Luke A. Rathbun,
Anthony M. Magliocco,
and Anil K. Bamezai
|
426-437 |
Addendum: Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report
Addendum: Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report |
https://doi.org/10.18632/oncotarget.28428
Mayank Rao,
Meenakshi Bhattacharjee,
Scott Shepard,
and Sigmund Hsu
|
438-438 |
HER3- A key survival pathway and an emerging therapeutic target in metastatic colorectal cancer and pancreatic ductal adenocarcinoma
HER3- A key survival pathway and an emerging therapeutic target in metastatic colorectal cancer and pancreatic ductal adenocarcinoma |
https://doi.org/10.18632/oncotarget.28421
Omkar Desai,
and Rui Wang
|
439-443 |
Targeting H3K27me3 loss in pediatric brain tumors - a perspective on epigenetically guided cancer therapy
Targeting H3K27me3 loss in pediatric brain tumors - a perspective on epigenetically guided cancer therapy |
https://doi.org/10.18632/oncotarget.28427
Michael Goldstein
|
444-447 |
Correction: A novel mechanism of regulation of the oncogenic transcription factor GLI3 by toll-like receptor signaling
Correction: A novel mechanism of regulation of the oncogenic transcription factor GLI3 by toll-like receptor signaling |
https://doi.org/10.18632/oncotarget.28430
Stephan J. Matissek,
Mona Karbalivand,
Weiguo Han,
Ava Boutilier,
Estefania Yzar-Garcia,
Laura L. Kehoe,
Devin Storm Gardner,
Adam Hage,
Krista Fleck,
Vicki Jeffers,
Ricardo Rajsbaum,
and Sherine F. Elsawa
|
448-448 |
Addendum: Histological and molecular analysis of a progressive diffuse intrinsic pontine glioma and synchronous metastatic lesions: a case report
Addendum: Histological and molecular analysis of a progressive diffuse intrinsic pontine glioma and synchronous metastatic lesions: a case report |
https://doi.org/10.18632/oncotarget.28286
Javad Nazarian,
Gary E. Mason,
Cheng Ying Ho,
Eshini Panditharatna,
Madhuri Kambhampati,
L. Gilbert Vezina,
Roger J. Packer,
and Eugene I. Hwang
|
449-449 |
Development and implementation of an automated and highly accurate reporting process for NGS-based clonality testing
Development and implementation of an automated and highly accurate reporting process for NGS-based clonality testing |
https://doi.org/10.18632/oncotarget.28429
Sean T. Glenn,
Phillip M. Galbo Jr.,
Jesse D. Luce,
Kiersten Marie Miles,
Prashant K. Singh,
Manuel J. Glynias,
and Carl Morrison
|
450-461 |
The molecular dialogue between the tumor cells and fibroblasts
The molecular dialogue between the tumor cells and fibroblasts |
https://doi.org/10.18632/oncotarget.28405
Ramesh Butti,
and Gopal C. Kundu
|
462-463 |
Correction: miR-29a-3p suppresses cell proliferation and migration by downregulating IGF1R in hepatocellular carcinoma
Correction: miR-29a-3p suppresses cell proliferation and migration by downregulating IGF1R in hepatocellular carcinoma |
https://doi.org/10.18632/oncotarget.28398
Xiao Wang,
Shasha Liu,
Ling Cao,
Tengfei Zhang,
Dongli Yue,
Liping Wang,
Yu Ping,
Qianyi He,
Chaoqi Zhang,
Meng Wang,
Xinfeng Chen,
Qun Gao,
Dan Wang,
Zhen Zhang,
Fei Wang,
Li Yang,
Jieyao Li,
Lan Huang,
Bin Zhang,
and Yi Zhang
|
464-465 |
G-protein-coupled receptor 141 mediates breast cancer proliferation and metastasis by regulating oncogenic mediators and the p-mTOR/p53 axis
G-protein-coupled receptor 141 mediates breast cancer proliferation and metastasis by regulating oncogenic mediators and the p-mTOR/p53 axis |
https://doi.org/10.18632/oncotarget.28433
Monalisa Parija,
Amit K. Adhya,
and Sandip K. Mishra
|
466-480 |
Correction: Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer
Correction: Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer |
https://doi.org/10.18632/oncotarget.28426
Astrid Escudero-Esparza,
Michael Bartoschek,
Chrysostomi Gialeli,
Marcin Okroj,
Sioned Owen,
Karin Jirström,
Akira Orimo,
Wen G. Jiang,
Kristian Pietras,
and Anna M. Blom
|
481-482 |
GBP3-STING interaction in glioblastoma coordinates autophagy, anti-oxidative, and DNA repair programs in response to temozolomide
GBP3-STING interaction in glioblastoma coordinates autophagy, anti-oxidative, and DNA repair programs in response to temozolomide |
https://doi.org/10.18632/oncotarget.28370
Jun Ma,
Ziyu Wang,
Clark C. Chen,
and Ming Li
|
483-484 |
Role of creatine shuttle in colorectal cancer cells
Role of creatine shuttle in colorectal cancer cells |
https://doi.org/10.18632/oncotarget.28436
Mayu Kita,
Rina Fujiwara-Tani,
Shingo Kishi,
Shiori Mori,
Hitoshi Ohmori,
Chie Nakashima,
Kei Goto,
Takamitsu Sasaki,
Kiyomu Fujii,
Isao Kawahara,
Ujjal Kumar Bhawal,
Yi Luo,
and Hiroki Kuniyasu
|
485-501 |
Addendum: Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy
Addendum: Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy |
https://doi.org/10.18632/oncotarget.28445
Stephanie A. Toll,
Hung N. Tran,
Jennifer Cotter,
Alexander R. Judkins,
Benita Tamrazi,
Jaclyn A. Biegel,
Girish Dhall,
Nathan J. Robison,
Kaaren Waters,
Palak Patel,
Robert Cooper,
and Ashley S. Margol
|
502-502 |
Targeting the Src N-terminal regulatory element in cancer
Targeting the Src N-terminal regulatory element in cancer |
https://doi.org/10.18632/oncotarget.28434
Betlem Mezquita,
Marjorie Reyes-Farias,
and Miquel Pons
|
503-513 |
Latest updates on MET targeted therapy for EXON 14 mutations in lung cancer
Latest updates on MET targeted therapy for EXON 14 mutations in lung cancer |
https://doi.org/10.18632/oncotarget.28419
Mira Al Jaberi,
Wolfgang Clough,
and Samir Dalia
|
514-514 |
Addendum: ROS1-GOPC/FIG: a novel gene fusion in hepatic angiosarcoma
Addendum: ROS1-GOPC/FIG: a novel gene fusion in hepatic angiosarcoma |
https://doi.org/10.18632/oncotarget.28448
Eric I. Marks,
Sahithi Pamarthy,
Don Dizon,
Ari Birnbaum,
Evgeny Yakirevich,
Howard Safran,
and Benedito A. Carneiro
|
515-515 |
Retraction: Inhibition of microRNA-218 reduces HIF-1α by targeting on Robo1 in mice aortic endothelial cells under intermittent hypoxia
Retraction: Inhibition of microRNA-218 reduces HIF-1α by targeting on Robo1 in mice aortic endothelial cells under intermittent hypoxia |
https://doi.org/10.18632/oncotarget.28449
Kai-Xiong Liu,
Qin Chen,
Gong-Ping Chen,
Jian-Chai Huang,
Jie-Feng Huang,
Xin-Ru He,
Ting Lin,
and Qi-Chang Lin
|
516-516 |
Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC)
Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC) |
https://doi.org/10.18632/oncotarget.28444
Hazem I. Assi,
Maroun Bou Zerdan,
Mohammad Hodroj,
Makram Khoury,
Nour Sabiha Naji,
Ghid Amhaz,
Reine Abou Zeidane,
and Fadi El Karak
|
517-525 |
Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanoma
Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanoma |
https://doi.org/10.18632/oncotarget.28441
Silvia Pietrobono,
and Barbara Stecca
|
526-527 |
Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression
Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression |
https://doi.org/10.18632/oncotarget.28442
Mohammad Salman Akhtar,
Naseem Akhter,
Arshi Talat,
Raed A. Alharbi,
Abdulmajeed A.A. Sindi,
Faisal Klufah,
Hanan E. Alyahyawi,
Abdulmohsen Alruwetei,
Abrar Ahmad,
Mazin A. Zamzami,
SVS Deo,
Syed Akhtar Husain,
Osama A. Badi,
and Mohammad Jahir Khan
|
528-541 |
Addendum: Laser speckle flowgraphy in juxtapapillary retinal capillary hemangioblastoma: a case report on natural course and therapeutic effect
Addendum: Laser speckle flowgraphy in juxtapapillary retinal capillary hemangioblastoma: a case report on natural course and therapeutic effect |
https://doi.org/10.18632/oncotarget.28297
Mizuho Mitamura,
Satoru Kase,
Kiriko Hirooka,
and Susumu Ishida
|
542-542 |
Deconstructing the role of MALAT1 in MAPK-signaling in melanoma: insights from antisense oligonucleotide treatment
Deconstructing the role of MALAT1 in MAPK-signaling in melanoma: insights from antisense oligonucleotide treatment |
https://doi.org/10.18632/oncotarget.28447
Valentin Feichtenschlager,
Yixuan James Zheng,
Wilson Ho,
Linan Chen,
Ciara Callanan,
Christopher Chen,
Albert Lee,
Jose Ortiz,
Klemens Rappersberger,
and Susana Ortiz-Urda
|
543-560 |